168 related articles for article (PubMed ID: 10417034)
21. Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction.
Hernández-Díaz S; Varas-Lorenzo C; García Rodríguez LA
Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):266-74. PubMed ID: 16611201
[TBL] [Abstract][Full Text] [Related]
22. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
[TBL] [Abstract][Full Text] [Related]
23. Use of nonsteroidal anti-inflammatory drugs among healthy people and specific cerebrovascular safety.
Fosbøl EL; Olsen AM; Olesen JB; Andersson C; Kober L; Torp-Pedersen C; Gislason GH
Int J Stroke; 2014 Oct; 9(7):943-5. PubMed ID: 23088217
[TBL] [Abstract][Full Text] [Related]
24. Non-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case-time-control study.
Sondergaard KB; Weeke P; Wissenberg M; Schjerning Olsen AM; Fosbol EL; Lippert FK; Torp-Pedersen C; Gislason GH; Folke F
Eur Heart J Cardiovasc Pharmacother; 2017 Apr; 3(2):100-107. PubMed ID: 28025218
[TBL] [Abstract][Full Text] [Related]
25. Hypersensitivity reactions associated with exposure to naproxen and ibuprofen: a cohort study.
McMahon AD; Evans JM; MacDonald TM
J Clin Epidemiol; 2001 Dec; 54(12):1271-4. PubMed ID: 11750197
[TBL] [Abstract][Full Text] [Related]
26. Worldwide safety experience with diclofenac.
Catalano MA
Am J Med; 1986 Apr; 80(4B):81-7. PubMed ID: 3518436
[TBL] [Abstract][Full Text] [Related]
27. Ibuprofen versus other non-steroidal anti-inflammatory drugs: use in general practice and patient perception.
Seager JM; Cullen DJ; Pearson G; Holmes S; Doherty M; Wilson JV; Garrud P; Garner S; Maynard A; Logan RF; Hawkey CJ
Aliment Pharmacol Ther; 2000 Feb; 14(2):187-91. PubMed ID: 10651659
[TBL] [Abstract][Full Text] [Related]
28. Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen.
Weinstein RB; Ryan PB; Berlin JA; Schuemie MJ; Swerdel J; Fife D
Drug Saf; 2020 Sep; 43(9):927-942. PubMed ID: 32500272
[TBL] [Abstract][Full Text] [Related]
29. Ibuprofen does not seem to increase global malformation risk but NSAID use in late pregnancy remains a concern.
Damase-Michel C; Hurault-Delarue C
Evid Based Med; 2014 Apr; 19(2):74. PubMed ID: 24113232
[No Abstract] [Full Text] [Related]
30. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.
Hippisley-Cox J; Coupland C; Logan R
BMJ; 2005 Dec; 331(7528):1310-6. PubMed ID: 16322018
[TBL] [Abstract][Full Text] [Related]
31. Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs.
Lewis JD; Kimmel SE; Localio AR; Metz DC; Farrar JT; Nessel L; Brensinger C; McGibney K; Strom BL
Gastroenterology; 2005 Dec; 129(6):1865-74. PubMed ID: 16344055
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular safety of using non-steroidal anti-inflammatory drugs for gout: a Danish nationwide case-crossover study.
Bech-Drewes A; Bonnesen K; Hauge EM; Schmidt M
Rheumatol Int; 2024 Jun; 44(6):1061-1069. PubMed ID: 38581450
[TBL] [Abstract][Full Text] [Related]
33. The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial.
Solomon DH; Husni ME; Libby PA; Yeomans ND; Lincoff AM; Lϋscher TF; Menon V; Brennan DM; Wisniewski LM; Nissen SE; Borer JS
Am J Med; 2017 Dec; 130(12):1415-1422.e4. PubMed ID: 28756267
[TBL] [Abstract][Full Text] [Related]
34. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
Rahme E; Nedjar H; Bizzi A; Morin S
Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
[TBL] [Abstract][Full Text] [Related]
35. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Langman MJ; Jensen DM; Watson DJ; Harper SE; Zhao PL; Quan H; Bolognese JA; Simon TJ
JAMA; 1999 Nov; 282(20):1929-33. PubMed ID: 10580458
[TBL] [Abstract][Full Text] [Related]
36. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
[TBL] [Abstract][Full Text] [Related]
37. [Cardiovascular side effects of non-steroidal anti-inflammatory drugs in the light of recent recommendations. Diclofenac is not more dangerous].
Horváth VJ; Tabák GÁ; Szabó G; Putz Z; Koós CG; Lakatos P
Orv Hetil; 2015 Mar; 156(13):516-20. PubMed ID: 25796279
[TBL] [Abstract][Full Text] [Related]
38. Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam.
Singh G; Lanes S; Triadafilopoulos G
Am J Med; 2004 Jul; 117(2):100-6. PubMed ID: 15234645
[TBL] [Abstract][Full Text] [Related]
39. Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genotype.
van Dijk KN; Plat AW; van Dijk AA; Piersma-Wichers M; de Vries-Bots AM; Slomp J; de Jong-van den Berg LT; Brouwers JR
Thromb Haemost; 2004 Jan; 91(1):95-101. PubMed ID: 14691574
[TBL] [Abstract][Full Text] [Related]
40. Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention.
Manoukian AV; Carson JL
Drug Saf; 1996 Jul; 15(1):64-71. PubMed ID: 8862964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
